News & Media
Learn more about the latest happenings at Otsuka. Select to see US news or read our press releases. You can also stay up to date with our global news in the link below.
Media Contact:
Senior Director, External Communications,
Otsuka America Pharmaceutical, Inc
Bob Oliver, President and CEO of Otsuka America Pharmaceutical, Inc. (OAPI) was named to Ebony Magazine’s 2016 Power 100 list of the world’s most influential and inspiring African Americans. He was recognized for his contributions to helping OAPI create a successful commercial organization, especially in the mental health space. “I would like to thank Ebony for this honor. I am humbled to
For the third year, the Community Innovation Awards program honors four local organizations for innovative approaches to improving mental health (Washington, D.C., (NOVEMBER 16, 2016) – The National Alliance on Mental Illness (NAMI) and the National Council for Behavioral Health (National Council), along with Otsuka America Pharmaceutical, Inc. and Lundbeck, announced the winners of the
Labeling update includes clinical data on use of REXULTI in adult patients with schizophrenia in the maintenance phase of treatmentApproval was based on REXULTI demonstrating efficacy and safety in a long-term randomized withdrawal trialThe trial demonstrated a statistically significant (p < 0.0001) longer time to relapse in patients treated with REXULTI compared to placebo-treated
US NEWS 26 JULY 2016 A new technology that analyzes a person’s natural speech to detect and monitor Alzheimer’s disease and other cognitive disorders has won the AGE-WELL Pitch Competition: Technology to Support People with Dementia. The new tablet-based assessment tool records short samples of a person’s speech as they describe a picture – even a family photo – on the screen. It